Annotation Detail for GNL2

Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of GNL2 mRNA | affects expression | 21346803
|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of GNL2 mRNA | affects expression | 21346803
|
| D000082 |
Acetaminophen |
Acetaminophen affects the expression of GNL2 mRNA | affects expression | 17562736
|
| D001104 |
Arbutin |
Arbutin results in increased expression of GNL2 mRNA | increases expression | 17103032
|
| D016572 |
Cyclosporine |
Cyclosporine results in increased expression of GNL2 mRNA | increases expression | 20106945
|
| C006253 |
pirinixic acid |
pirinixic acid results in increased expression of GNL2 mRNA | increases expression | 18445702
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
| MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.94 | 16434500 |
| MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.36 | 10982225 |
| MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.40 | 18445737 |
| MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.47 | 19483382 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
4.73 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
4.73 | 16705839 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.73 | 3084413 |
| MESH:D002386 |
Cataract |
|
Acetaminophen |
2.75 | 10977129 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.27 | 6135515 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
7.27 | 12371664 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
8.53 | 19486331 |
| MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.53 | 19176532 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
12.32 | 18551238 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
12.32 | 18551238 |
| MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
6.62 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.62 | 21346803 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.62 | 11743745 12958197 18713872 19416960 12705907 11834606 18071297 16109766 11739529 11461765 17906064 16081117 10663392 11287661 12392966 19739265 12153990 10915739 12594235 16227642 12540782 14986274 17522070 16177239 17562736 15968718 16393943 19085960 19923254 16781746 2444490 14725611 19370779 19164858 15619225 11529661 16485898 11421492 10774834 14550746 19420014 |
| MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.62 | 19426721 |
| MESH:D004487 |
Edema |
|
pirinixic acid |
2.80 | 12083418 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
8.66 | 19224547 |
| MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.66 | 19236843 20131406 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.56 | 12639820 12168785 |
| MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.19 | 16983495 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.68 | 8708960 |
| MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.88 | 15720958 |
| MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.41 | 16221962 18467677 19176532 19772884 |
| MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.95 | 16870215 |
| MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.49 | 20558911 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.19 | 10903974 |
| MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.82 | 16306350 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.96 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
6.34 | 12587719 15629191 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
6.34 | 18776723 10903974 8314463 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
13.97 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
13.97 | 16705839 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
13.97 | 12371664 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
| MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.69 | 19784758 19014921 16610002 19460945 16611625 12969438 12587719 11587558 |
| MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.54 | 17185352 16871587 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
4.74 | 7678174 |
| MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.74 | 16377806 20007298 15890375 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
2.72 | 6135515 2876784 2876786 |
| MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.98 | 19513568 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.31 | 16801185 |
| MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
| MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.19 | 16411023 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
11.94 | 18551238 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
11.94 | 7678174 18551238 |
| MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.08 | 17405874 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.96 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.57 | 19348381 18481113 |
| MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.14 | 18514411 |
| MESH:D009765 |
Obesity |
|
pirinixic acid |
1.87 | 20558911 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
9.92 | 16049721 12819281 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.92 | 16049721 |
| MESH:D010146 |
Pain |
|
Acetaminophen |
2.65 | 16870215 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.51 | 12371664 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.31 | 16882103 |
| MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.56 | 18551238 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.56 | 18551238 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
5.36 | 16049721 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
5.36 | 16049721 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
13.58 | 10091137 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
13.58 | 10091137 |
| MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.33 | 10982225 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.50 | 1336536 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.96 | 17120751 |
| Pathway ID |
Pathway Name |
|---|
| KEGG:03008 |
Ribosome biogenesis in eukaryotes |